Kexing Biopharm Co.,Ltd.

About Kexing Biopharm Co.,Ltd.

Kexing Biopharms  integrates R&D, manufacture, and sales of biopharmaceuticals. 
Its production site offers Recombinant Human Erythropoietin Injection(EPO), Recombinant Human Granulocyte Colony-stimulating Factor Injection(rh-G-CSF)Filgrastim, and Combined Clostridium Butyricum and Bifidobacterium Powders, Live for clinical and commercial use. I
The company develops recombinant genetic biological drugs and micro-ecological preparation, to serve the clinical treatment needs of kidney diseases, tumor, and gastrointestin...

  • CN
  • 2022
    On CPHI since
  • 100 - 249
    Employees
Company types
Biopharmaceutical company
Primary activities
Biopharmaceutical
Contact info
Meet us at

CPHI Frankfurt 2022

Messe Frankfurt, Germany
1-3 November 2022